Provided By PR Newswire
Last update: Oct 25, 2024
NEW YORK, Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.com23.2
-0.68 (-2.85%)
Find more stocks in the Stock Screener
Based on a technical and fundamental analysis of NASDAQ:PGNY we can say: PROGYNY INC (NASDAQ:PGNY), a strong growth stock, setting up for a breakout.